Skip to content
OpenCapital
Get started

AdvanSix ASIX Caprolactam — Sales

Other product segments

Plant Nutrients
$140.64M+9.7%
Chemical Intermediates
$107.31M+14.5%
Nylon
$88.47M+0.1%

Similar metrics at other companies

Johnson & Johnson logo
JNJCAPLYTA — Sales to customers (Note 9)
$270M—
Ligand Pharmaceuticals logo
LGNDCaptisol — Total revenues and income
$8.65M-35.7%
Johnson & Johnson logo
JNJCAPLYTA — Percent Change (as a percent)
0%—
LyondellBasell Industries N.V. logo
LYBPolypropylene — Total
$1.34B-12.6%
Smurfit Kappa Group logo
SWLATAM — Net Sales
$540M+5.3%
Avient logo
AVNTLatin America — Total Sales
$45.6M+1.3%

Other financials

Income statement

See full
Revenue$404.2M+7.0%
Gross profit$3.8M-92.9%
Net income-$15.5M-167%
EPS (diluted)-$0.58-167%

Balance sheet

See full
Cash & equivalents$17.6M+111%
Total debt$156.4M+7.4%
Total equity$796.3M+0.2%
Total assets$1.7B+5.2%

Cash flow

See full
Operating cash flow-$15.3M-234%
CapEx$35.9M+5.5%
Free cash flow-$51.3M-127%

Valuation

See full
Market cap$535.14M-14.8%
Enterprise value$673.92M-11.9%
P/E40.6×+33.2×
P/S0.4×-0.1×

Profitability

See full
Gross margin7.4%-5.6pp
Net margin0.9%-4.6pp
FCF margin-1.4%—

Returns & leverage

See full
Return on equity1.7%-9.6pp
Debt / equity0.2×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by AdvanSix in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: AdvanSix’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdvanSix's caprolactam — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdvanSix's caprolactam — sales?
AdvanSix (ASIX) reported caprolactam — sales of $67.77M in Q1 2026.
How has AdvanSix's caprolactam — sales changed year-over-year?
AdvanSix's caprolactam — sales increased by 0.5% year-over-year, from $67.43M to $67.77M.
What is the long-term trend for AdvanSix's caprolactam — sales?
Over 4 years (2021 to 2025), AdvanSix's caprolactam — sales has grown at a -3.7% compound annual growth rate (CAGR), from $316.13M to $271.37M.
What does caprolactam — sales mean?
Represents the total gross revenue generated from the sale of caprolactam products within a specific reporting period. This metric reflects the market demand and pricing power for this chemical intermediate used in the production of Nylon 6 resins and fibers.